Transcatheter aortic valve replacement (TAVR) has replaced surgical aortic valve
replacement as the new gold standard in elderly patients with severe aortic valve stenosis …

Since the first groundbreaking procedure in 2002, transcatheter aortic valve implantation
(TAVI) has revolutionized the management of aortic stenosis (AS). Through striking …

Background Procedural success and clinical outcomes after transcatheter aortic valve
replacement (TAVR) have improved, but residual aortic regurgitation (AR) and new …

Objectives We sought to evaluate the safety, efficacy and feasibility of same‐day discharge
after uncomplicated, minimalist TAVR. Background At the start of the COVID‐19 pandemic …

Objectives The aim of this study was to determine the safety and efficacy of same-day
discharge (SDD) after transcatheter aortic valve replacement (TAVR) during the COVID-19 …

Background The treatment of aortic stenosis is evolving rapidly. Pace of change in the care
of patients undergoing transcatheter aortic valve replacement (TAVR) and surgical aortic …

Transcatheter aortic valve implantation (TAVI) went through a huge evolution in the last
decades. Previously performed under general anesthesia, with transoperative …

Abstract Background and Aims There is significant potential to streamline the clinical
pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose …

Methods FAST-TAVI II is a prospective, multicentre, cluster, randomized, controlled study
including patients with severe symptomatic aortic stenosis, who had transfemoral TAVI. The …

Background Currently, there are no recommendations regarding the minimum duration of in-
hospital monitoring after transfemoral (TF) transcatheter aortic valve replacement (TAVR) …